Type
BCG vaccines: WHO position paper – February 2018. Releve epidemiologique hebdomadaire [Internet]. 2018;93(8):73-96. Available from: http://apps.who.int/iris/bitstream/10665/260306/1/WER9308.pdf
View
Type
Shoemaker. Molecular biology and mycobacteria. Seminars in respiratory infections. 1986;1(4):265-9.
View
Type
Chaturvedi, Singh, Sinha. Immunoreactive antigens of a candidate leprosy vaccine: Mycobacterium habana. Leprosy review [Internet]. 1995;66(1):31-8. Available from: http://leprev.ilsl.br/pdfs/1995/v66n1/pdf/v66n1a05.pdf
View
Type
Sterne, Turner, Fine PE, Parry, Lucas, Ponnighaus, et al. Testing for antibody to human immunodeficiency virus type 1 in a population in which mycobacterial diseases are endemic. The Journal of infectious diseases. 1995;172(2):543-6.
View
Type
Bretscher. Prospects for low dose BCG vaccination against tuberculosis. Immunobiology. 1994;191(4-5):548-54.
View
Type
Kaplan. Cytokine regulation of disease progression in leprosy and tuberculosis. Immunobiology. 1994;191(4-5):564-8.
View
Type
Bermudez. Use of liposome preparation to treat mycobacterial infections. Immunobiology. 1994;191(4-5):578-83.
View
Type
Bermudez, Kaplan. Recombinant cytokines for controlling mycobacterial infections. Trends in microbiology. 1995;3(1):22-7.
View
Type
Lagrange. [A very current aspect of the fate of infectious diseases: tuberculosis, leprosy and opportunistic mycobacteria]. Bulletin de l'Academie nationale de medecine. 1995;179(4):805-20; discussion 820-2.
View
Type
Medda, Das, Mahato, Mahadevan, Basu. Glycoside-bearing liposomal delivery systems against macrophage-associated disorders involving Mycobacterium leprae and Mycobacterium tuberculosis. Indian journal of biochemistry & biophysics. 1995;32(3):147-51.
View